A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer. [electronic resource]
Producer: 20110916Description: 694-9 p. digitalISSN:- 1573-0646
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Erlotinib Hydrochloride
- Female
- Humans
- Immunohistochemistry
- Isoflavones -- administration & dosage
- Kaplan-Meier Estimate
- Male
- Middle Aged
- NF-kappa B -- metabolism
- Neoplasm Staging
- Pancreatic Neoplasms -- drug therapy
- Phosphorylation
- Proto-Oncogene Proteins c-akt -- metabolism
- Quinazolines -- administration & dosage
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.